Remove Individual Remove Patients Remove Specialization Remove Workshop
article thumbnail

At Long Last, FDA Unveils Plan for Rare Disease Innovation Hub

FDA Law Blog

We also commend and congratulate the legions of rare disease patient advocates and the leadership of the EveryLife Foundation for Rare Diseases (“ELF”) who championed the advocacy efforts that led to this important milestone. By Sarah Wicks & James E. Valentine & Frank J.

article thumbnail

Wrapping up 2022! (Residency Life, Mom Life, and Blog Milestones)

Aspiring Minority Doctor

I'm just seriously so blessed to have such an amazing daughter and I'm even more so grateful that I was able to spend her special day with her and celebrate in a way that she wanted. I continue to be grateful for each and every individual who takes the time out of their busy lives to read my blog. Thankful for you!

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Clinical Trials Join the Remote Work Revolution: FDA’s New Draft Guidance on Decentralized Clinical Trials

FDA Law Blog

mobile applications to capture patient-reported outcomes through questionnaires). FDA has also launched a series of five public workshops on issues related to DHTs in regulatory decision-making. DHTs include monitoring instruments (e.g., activity trackers, glucose monitors) and software (e.g.,

Clinic 59
article thumbnail

Writing for the Lay Public: Rosanne Leipzig and Louise Aronson

GeriPal

We have two authors, books, op-eds, prolific authors, and today’s podcast is a two-part special. Rosanne: I think I was motivated by the number of times patients asked me to get rid of their pot-bellies, quite honestly. And my patients started coming in talking about why didn’t you ever recommend that to me?

IT 106